(Health-NewsWire.Net, December 10, 2016 ) This report provides comprehensive information on the therapeutic development for Plague, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Plague and special features on late-stage and discontinued projects.
For more information about this report at http://www.reportsweb.com/plague-pipeline-review-h2-2015
Scope:
- The report provides a snapshot of the global therapeutic landscape of Plague - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Plague and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Plague products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Plague pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001170989/sample
Reasons to buy:
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Plague - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Plague pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001170989/discount
List of Tables: Number of Products under Development for Plague, H2 2015 8 Number of Products under Development for Plague-Comparative Analysis, H2 2015 9 Number of Products under Development by Companies, H2 2015 10 Number of Products under Investigation by Universities/Institutes, H2 2015 11 Comparative Analysis by Clinical Stage Development, H2 2015 12 Comparative Analysis by Early Stage Development, H2 2015 13 Comparative Analysis by Unknown Stage Development, H2 2015 14 Products under Development by Companies, H2 2015 15 Products under Investigation by Universities/Institutes, H2 2015 16 Plague-Pipeline by Aradigm Corporation, H2 2015 17 Plague-Pipeline by Grifols, S.A., H2 2015 18 Plague-Pipeline by iBio, Inc., H2 2015 19 Plague-Pipeline by Mucosis B.V., H2 2015 20 Plague-Pipeline by Syntiron LLC, H2 2015 21 Plague-Pipeline by Tetraphase Pharmaceuticals Inc., H2 2015 22 Assessment by Monotherapy Products, H2 2015 23 Assessment by Combination Products, H2 2015 24 Number of Products by Stage and Target, H2 2015 26 Number of Products by Stage and Mechanism of Action, H2 2015 28 Number of Products by Stage and Route of Administration, H2 2015 30 Number of Products by Stage and Molecule Type, H2 2015 32 Plague Therapeutics-Recent Pipeline Updates, H2 2015 52 Plague-Dormant Projects, H2 2015 55 Plague-Discontinued Products, H2 2015 56
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|